Lumican expression is associated with the formation of mesenchyme-like elements in salivary pleomorphic adenomas

Journal of Pathology

Volumn 203, Issue 4, 2004, Pages 953-960

  Kusafuka, Kimihide ^a,b   Ishiwata, Toshiyuki ^c   Sugisaki, Yuichi ^c   Takemura, Tamiko ^b   Kusafuka, Michi ^a   Hisha, Hiroko ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Immunohistochemistry; In situ hybridization; Lumican; Pleomorphic adenoma; Salivary glands

Indexed keywords

HYALIN; LUMICAN; MESSENGER RNA; PEPSIN A;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MESENCHYME; MYOEPITHELIUM CELL; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SALIVARY GLAND TUMOR;

ADENOMA, PLEOMORPHIC; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; KERATAN SULFATE; MESODERM; NEOPLASM PROTEINS; PROTEOCHONDROITIN SULFATES; RNA, MESSENGER; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS;

EID: 4143149752     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1599     Document Type: Article

References (44)

1. Grishman E. Histochemical analysis of mucopolysaccharides occurring in mucin-producing tumors. Mixed tumors of the parotid gland, colloid carcinomas of the breast, and myxomas. Cancer 1952; 4: 700-707.
2. Azzopardi JG, Smith OD. Salivary gland tumors and their mucins. J Pathol Bacteriol 1959; 77: 131-140.
3. Lovell D, Briggs JC, Schorah CJ. Chemical analysis of acid mucopolysaccharides of mixed salivary tumors. Br J Cancer 1966; 20: 463-468.
4. Quintarelli G, Robinson L. The glycosaminoglycans of salivary gland tumors. A histochemical characterization and a critical evaluation. Am J Pathol 1966; 51: 19-37.
5. Takeuchi J, Sobue M, Yoshida M, Esaki T, Katoh Y. Pleomorphic adenoma of the salivary gland with special reference to histochemical and electron microscopic studies and biochemical analysis of glycosaminoglycans in vivo and in vitro. Cancer 1975; 36: 1771-1789.
6. Takeuchi J, Sobue M, Yoshida M, Sato E. Glycosaminoglycan-synthetic activity of pleomorphic adenoma. Adenoid cystic carcinoma and non-neoplastic tubuloacinar cells of the salivary gland . Cancer 1978; 42: 202-208.
7. Toida M, Takeuchi J, Kazuo H, et al. Histochemical studies of intercellular components of salivary gland tumors with special reference of glycosaminoglycan, laminin and vascular elements. Virchows Arch A 1984; 403: 15-26.
8. Zhao M, Takata T, Ogawa I, Miyauchi M, Itoh H, Nikai H. Localization of glycoaminoglycans (GAGs) in pleomorphic adenoma (PA) of salivary glands: an immunohistochemical and histochemical evaluation. J Oral Pathol Med 1998; 27: 272-277.
9. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-870.
10. Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem 1989; 264: 8012-8018.
11. Zhao M, Takata T, Ogawa I, Yada T, Kimata K, Nikai H. Immunohistochemical evaluation of the small and large proteoglycans in pleomorphic adenoma of salivary glands. J Oral Pathol Med 1999; 28: 37-42.
12. Kusafuka K, Hiraki Y, Shukunami C, Yamaguchi A, Kayano T, Takemura T. Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis. Am J Pathol 2001; 158: 1465-1472.
13. Blochberger TC, Vergnes JP, Hempel J, Hassell JR. cDNA to chick lumican (corneal keratan sulphate proteoglycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem 1992; 267: 346-352.
14. Funderburgh JL, Funderburgh ML, Brown SJ, et al. Sequence and structural implications of the bovine corneal keratan sulphate proteoglycan core protein. J Biol Chem 1993; 268: 11 874-11 880.
15. Funderburgh JL, Funderburgh ML, Mann MM, Conrad GW. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J Biol Chem 1991; 266: 24 773-24 777.
16. Grover J, Vhem X-N, Korenberg JR, Roughley PJ. The human lumican gene: organization, chromosomal location, and expression in articular cartilage. J Biol Chem 1995; 270: 21 942-21 949.
17. Heinegard D, Larssen T, Somarinn Y, Franzen A, Paulsson M, Hedbom E. Two novel matrix proteins isolated from articular cartilage show distributions among connective tissues. J Biol Chem 1986; 261: 13 866-13 872.
18. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997; 32: 141-174.
19. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 1986; 83: 7683-7687.
20. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 1989; 264: 4571-4576.
21. Oldberg AP, Antonsson P, Lindblom K, Heinegard D. A collagen-binding 50 kd.protein (fibromodulin) is structurally related to the small interstitial proteoglycan PG-S1 and PG-S2 (decorin). EMBO J 1989; 8: 2601-2604.
22. Sztrolovics R, Alini M, Mort JS, Roughley PJ. Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine 1999; 24: 1715-1771.
23. Lu YP, Ishiwata T, Asano G. Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J Pathol 2002; 196: 324-330.
24. Naito Z, Ishiwata T, Kurban G, et al. Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. Int J Oncol 2002; 20: 943-948.
25. Dolhnikoff M, Morin J, Roughley PJ, Ludwig MS. Expression of lumican in human lung. Am J Respir Cell Mol Biol 1998; 19: 582-587.
26. Lu YP, Ishiwata T, Kawahara K, et al. Expression of lumican in human colorectal cancer cells. Pathol Int 2002; 52: 519-529.
27. Ishiwata T, Friess H, Buchler MW, Lopez ME, Korc M. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 1998; 153: 213-222.
28. Ishiwata T, Kornmarm M, Beger HG, Korc M. Enhanced fibroblast growth factor 5 in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut 1998; 43: 134-139.
29. Kusafuka K, Yamaguchi A, Kayano T, Fujiwara M, Takemura T. Expression of bone morphogenetic proteins in salivary pleomorphic adenomas. Virchows Arch 1998; 432: 247-253.
30. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of the bone morphogenetic protein-6 in salivary pleomorphic adenomas. Pathol Int 1999; 49: 1023-1027.
31. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of fibroblast growth factors (FGFs) and FGF receptor-1 in human normal salivary glands and pleomorphic adenomas. J Oral Pathol Med 1998; 27: 287-292.
32. Hiraki Y, Kono T, Sato M, Shukunami C, Kondo J. Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I. FEBS Lett 1997; 425: 321-324.
33. Hiraki Y, Inoue H, Iyama K, et al. Identification of chondromodulin-I as a novel endothelial cell growth inhibitor; purification and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem 1997; 272: 32 419-32 426.
34. Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun 1991; 175: 971-977.
35. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67: 609-652.
36. Fullwood NJ, Davies Y, Nieduszynski IA, Marcyniuk B, Ridgway AE, Quantock AJ. Cell surface-associated keratan sulfate on normal and migrating corneal endothelium. Invest Ophthalmol Vis Sci 1996; 7: 1256-1270.
37. Wight TN, Kinsella MG, Qwarnstrom EE. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 1992; 4: 793-801.
38. Leygue E, Snell L, Dotzlow H, et al. Expression of lumican in human breast carcinoma. Cancer Res 1998; 58: 1348-1352.
39. Leygue E, Snell L, Dotzlow H, et al. Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 2000; 192: 313-320.
40. Qin H, Ishiwata T, Asano G. Effects of the extracellular matrix on lumican expression in rat aortic smooth muscle cells in vitro. J Pathol 2001; 195: 604-608.
41. Melching LI, Cs-Szabo G, Roughley PJ. Analysis of proteoglycan messages in human articular cartilage by a competitive PCR technique. Matrix Biol 1997; 16: 1-11.
42. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM. Recurrent rearrangement in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet 1995; 10: 436-444.
43. Chakravarti S, Stallings RL, SunderRaj N, Cornuet P, Hassell JR. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics 1995; 27: 481-488.
44. Kools PFJ, Van de Ven WJM. Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OsA-CI osteosarcoma cells. Cancer Genet Cytogenet 1996; 91: 1-7.